Saturday, October 31, 2026

Credit Markets

4 articles

Global Private Credit Markets Crack as BDCs Cut Dividends 50% on Middle East Tensions

Global Private Credit Markets Crack as BDCs Cut Dividends 50% on Middle East Tensions

BlackRock TCP Capital and MidCap Financial slashed dividends by 50% in late February 2026 as Middle East geopolitical stress triggered worldwide flight to safety. Gold surged past $5,250 per ounce while private credit markets tightened across North America and Europe, signaling credit stress in the $1.6 trillion alternative lending sector.

ViaNews Editorial Team•
Apollo and BlackRock BDC Dividend Cuts Expose $1.4 Trillion Private Credit Stress

Apollo and BlackRock BDC Dividend Cuts Expose $1.4 Trillion Private Credit Stress

MidCap Financial and BlackRock TCP Capital slashed dividends 15-20% in late February 2026, triggering 8-9% share price drops as middle-market credit stress spreads across the $1.4 trillion global private credit market. Non-accrual loan rates doubled to 2.8% in Q4 2025 as borrowers face 12-14% refinancing costs, up from 8-10% in 2021-2022. The synchronized cuts by Apollo-backed and BlackRock-backed lenders signal systemic pressure in private credit markets that expanded rapidly during zero-rate c

ViaNews Editorial Team•
BlackRock Writes Renovo Home Partners Debt to Zero in US Home Services Shakeout

BlackRock Writes Renovo Home Partners Debt to Zero in US Home Services Shakeout

BlackRock has marked Renovo Home Partners debt at zero cents on the dollar, signaling complete equity wipeout at the US home services consolidator. The collapse follows a wave of leveraged buyouts in the sector that drew billions in private debt from 2020-2021, now facing maturity walls as interest rates rise globally.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com